Tap the vial. Confirm it's real. Then inject.
Unit-level authentication for Botox, dermal fillers, and aesthetic devices across the medspa channel — the gap regulators leave open.
Counterfeit and unapproved toxins and fillers reach clinics through unofficial supply. Once a vial is in the room, the injector has no fast way to prove it is genuine.
Diverted stock travels outside the authorized chain, where temperature handling is unknown. Compromised product looks identical to product handled correctly.
The medspa channel sits between distribution and clinical practice — a seam where serialization confirms the carton but no one authenticates the individual unit.
Aeroz binds dual-frequency, tamper-evident, unit-level authentication to each vial and device. The injector and the patient can tap-verify it with a phone before use — no app to download.
Every check writes to an append-only audit log, and cold-chain history travels with the unit — so temperature-compromised or counterfeit product fails the check.
A tap turns trust into proof. Before injection, the patient confirms the vial is genuine and was handled inside the authorized cold chain — and the clinic holds a defensible, time-stamped record that it was.
That record protects the patient from compromised product and protects the practice if a question is ever raised.
Injectables · unit-level
Verification · network
Cold chain · custody
Every verification — where, when, pass or fail — on the append-only log.
Intact or breached, per vial, the moment the state changes.
Temperature excursions for heat-sensitive toxins and fillers.
First-scan geography exposes product leaking outside the authorized channel.
Time-stamped proof the patient confirmed the unit before injection.
Each handoff from manufacture to chair as a unit-level event.
A fixed-fee Aeroz audit produces a written analysis of your counterfeit and diversion exposure across the medspa channel, a vial- and device-tagging assessment, and a scoped pilot plan with cost and timeline.
